Quality of Life Assessment After HSCT for Pediatric and Adults

Anna Barata; Heather Jim

doi:10.1007/978-3-030-02278-5_34

Quality of Life Assessment After HSCT for Pediatric and Adults

Review

In: The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 34.

Authors

Anna Barata^{1

2}, Heather Jim³

Book Editors

Enric Carreras¹, Carlo Dufour², Mohamad Mohty³, Nicolaus Kröger⁴

Affiliations

¹ Department of Hematology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
² José Carreras Leukemia Research Institute, Barcelona, Spain
³ Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA

Book Affiliations

¹ Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukemia Research Institute, Catalunya, Barcelona, Spain
² Hematology Unit, IRCCS Giannina Gaslini, Geneva, Switzerland
³ Department of Hematology, Pierre and Marie Curie University, Paris, France
⁴ Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppend, Hamburg, Germany

Excerpt

Methodological advances in the HCT field have increased the population of survivors worldwide. However, HCT is associated with significant morbidity that impairs survivors’ recovery and adversely affects their QoL.

Sections

Publication types

Review